Overview
Case Managers and Their Role in Improving Patient Outcomes in Idiopathic Pulmonary Fibrosis
IPF eNewsletter
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
This text-based activity will educate case managers and registered respiratory therapists (RRT) on the current management of idiopathic pulmonary fibrosis (IPF) and newer therapies that may impact treatment paradigms and patient outcomes. In addition to text, this activity also includes audio clips featuring faculty commentary and an "ask the expert" feature, which gives learners an opportunity to pose questions to the faculty; responses are posted on the discussion board for all learners to access. This format is conducive to viewing online and on tablets and smartphones.
This activity is intended for case managers and respiratory therapists involved in the management of patients with idiopathic pulmonary fibrosis (IPF).
Idiopathic pulmonary fibrosis (IPF) is a rare, progressive lung disease that greatly impacts patients’ quality of life and diminishes life expectancy. Newer therapies slow lung function decline. These therapies are used in combination with oxygen supplementation, pulmonary rehabilitation, symptomatic treatment, and supportive care. Case managers and respiratory therapists need education on the new therapies and supportive care to educate and counsel patients with IPF, as well as optimize their care.
Upon completion of this activity, participants will be able to:
• Discuss the burden of IPF on patient quality of life over the disease course
• Evaluate the efficacy, tolerability, and safety data for pharmacotherapies for IPF
• Counsel IPF patients and their caregivers on supportive care and pharmacologic approaches
• Assist with comprehensive care plans and appropriate referral to specialists
• Discuss the burden of IPF on patient quality of life over the disease course
• Evaluate the efficacy, tolerability, and safety data for pharmacotherapies for IPF
• Counsel IPF patients and their caregivers on supportive care and pharmacologic approaches
• Assist with comprehensive care plans and appropriate referral to specialists
Agenda topics include:
• Unraveling IPF
• Comprehensive treatment paradigms for IPF
• Transitions of Care for IPF patients
• Unraveling IPF
• Comprehensive treatment paradigms for IPF
• Transitions of Care for IPF patients
This activity is sponsored by the Academy for Continued Healthcare Learning (ACHL).
This activity is supported by an educational grant from Genentech, Inc.
Faculty
Kathleen Ann Fraser, MSN, MHA, RN-BC, CCM, CRRN
Executive Director
Case Management Society of America
Little Rock, AR
Kathleen Ann Fraser, MSN, MHA, RN-BC, CCM, CRRN
Executive Director
Case Management Society of America
Little Rock, AR
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.
Kathleen Ann Fraser, MSN, MHA, RN-BC, CCM, CRRN (Chair)
Financial relationships to disclose: None
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
Kathleen Ann Fraser, MSN, MHA, RN-BC, CCM, CRRN (Chair)
Financial relationships to disclose: None
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Clinicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pre-test, view the eNewsletter and complete a post-test and evaluation form. To receive credit, 80% must be achieved on the post-test. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
Inquiries may be directed to ACHL at (877) 444-8435, ext. 228.
Case Managers
This program has been pre-approved by the Commission for Case Manager Certification to provide continuing education credit to Certified Case Managers (CCMs). This course is approved for 1.0 CE contact hour.
Activity code: H00026793; Approval number: 170001799
Respiratory Therapists
AARC: 1.0 hour Continuing Respiratory Care Education
This course has been approved for Continuing Respiratory Education (CRCE) credit by the American Association for Respiratory Care. Course number: 148776000
This program has been pre-approved by the Commission for Case Manager Certification to provide continuing education credit to Certified Case Managers (CCMs). This course is approved for 1.0 CE contact hour.
Activity code: H00026793; Approval number: 170001799
Respiratory Therapists
AARC: 1.0 hour Continuing Respiratory Care Education
This course has been approved for Continuing Respiratory Education (CRCE) credit by the American Association for Respiratory Care. Course number: 148776000
